Skip to main content
Erschienen in: Rheumatology International 3/2012

01.03.2012 | Original Article

Evaluation of metabolic syndrome in patients with chronic low back pain

verfasst von: Mehmet Tuncay Duruöz, Yasemin Turan, Alev Gürgan, Hülya Deveci

Erschienen in: Rheumatology International | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of our study was to investigate the frequency of the metabolic syndrome in chronic low back pain and evaluate the differences in clinical and functional parameters in chronic low back pain patients with and without metabolic syndrome. Patients complaining of low back pain complaint lasting for at least 2 months were included in the study. In order to establish functional deficiency, Roland-Morris Disability Questionnaire, Istanbul Low Back Pain Disability Index and Oswestry Disability Index were used. To evaluate depression, Beck’s depression scale was used. The diagnosis of metabolic syndrome was made according to the criteria of National Cholesterol Education Program (NCEP) defined in 2001. For this; lumbar circumference around anterior iliac spine, arterial blood pressure, fasting blood glucose, plasma triglyceride levels and HDL cholesterol levels were noted down. Sixty patients (51 women) were included in the study. There was significant difference in terms of BMI (P = 0.034), age (P = 0.001), waist circumference (P = 0.048) and disease duration (P = 0.005) between chronic low back pain patients with and without metabolic syndrome. There was no significant difference in other parameters. Low back pain is a frequent complaint amongst people with obesity in the abdominal area. According to our results, elderly people, people with chronic low back pain and patients with high BMI are under risk for metabolic syndrome. For this reason this group of patients can be screened for metabolic syndrome and preventive measures can be taken.
Literatur
1.
Zurück zum Zitat Hitsumoto T, Takahashi M, Iizuka T, Shirai K (2007) Relationship between metabolic syndrome and early stage coronary atherosclerosis. J Atheroscler 14(6):294–302CrossRef Hitsumoto T, Takahashi M, Iizuka T, Shirai K (2007) Relationship between metabolic syndrome and early stage coronary atherosclerosis. J Atheroscler 14(6):294–302CrossRef
2.
Zurück zum Zitat Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ et al (2005) The metabolic syndrome: a concept hard to define. Arch Med Res 36(3):223–231PubMedCrossRef Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ et al (2005) The metabolic syndrome: a concept hard to define. Arch Med Res 36(3):223–231PubMedCrossRef
3.
Zurück zum Zitat Vrolix R, van Meijl LE, Mensink RP (2008) The metabolic syndrome in relation with the glycemic index and the glycemic load. Physiol Behav 94(2):293–299PubMedCrossRef Vrolix R, van Meijl LE, Mensink RP (2008) The metabolic syndrome in relation with the glycemic index and the glycemic load. Physiol Behav 94(2):293–299PubMedCrossRef
4.
Zurück zum Zitat Wen CJ, Lee YS, Lin WY et al (2008) The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly. Eur J Clin Invest 38(7):469–475PubMedCrossRef Wen CJ, Lee YS, Lin WY et al (2008) The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly. Eur J Clin Invest 38(7):469–475PubMedCrossRef
5.
Zurück zum Zitat Liu SJ, Guo ZR, Hu XS, Wu M, Chen FM, Kang GD et al (2008) Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up. Diabetes Res Clin Pract 81(1):117–123PubMedCrossRef Liu SJ, Guo ZR, Hu XS, Wu M, Chen FM, Kang GD et al (2008) Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up. Diabetes Res Clin Pract 81(1):117–123PubMedCrossRef
6.
Zurück zum Zitat Fagiolini A, Frank E, Turkin S, Houck PR, Soreca I, Kupfer DJ (2008) Metabolic syndrome in patients with bipolar disorder. J Clin Psychiatry 69(4):678–679PubMedCrossRef Fagiolini A, Frank E, Turkin S, Houck PR, Soreca I, Kupfer DJ (2008) Metabolic syndrome in patients with bipolar disorder. J Clin Psychiatry 69(4):678–679PubMedCrossRef
7.
Zurück zum Zitat Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC et al (2008) Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 health check-up Koreans. Gut 57(10):1360–1365PubMedCrossRef Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC et al (2008) Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 health check-up Koreans. Gut 57(10):1360–1365PubMedCrossRef
8.
Zurück zum Zitat Liou CW, Tan TY, Lin TK, Wang PW, Yip HK (2008) Metabolic syndrome and three of its components as risk factors for recurrent ischaemic stroke presenting as large-vessel infarction. Eur J Neurol 15(8):802–809PubMedCrossRef Liou CW, Tan TY, Lin TK, Wang PW, Yip HK (2008) Metabolic syndrome and three of its components as risk factors for recurrent ischaemic stroke presenting as large-vessel infarction. Eur J Neurol 15(8):802–809PubMedCrossRef
9.
Zurück zum Zitat Roland M, Morris R (1983) A study of the natural history of low back pain: part 1. Development of a reliable and sensitive measure of disability in low-back pain. Spine 8:141–144PubMedCrossRef Roland M, Morris R (1983) A study of the natural history of low back pain: part 1. Development of a reliable and sensitive measure of disability in low-back pain. Spine 8:141–144PubMedCrossRef
10.
Zurück zum Zitat Cakmak A, Yücel B, Ozyalcın SN, Bayraktar B, Ural HI, Duruöz MT et al (2004) The frequency and associated factors of low back pain among a younger population in Turkey. Spine 29(14):1567–1572PubMedCrossRef Cakmak A, Yücel B, Ozyalcın SN, Bayraktar B, Ural HI, Duruöz MT et al (2004) The frequency and associated factors of low back pain among a younger population in Turkey. Spine 29(14):1567–1572PubMedCrossRef
11.
Zurück zum Zitat Duruoz T, Cerrahoglu L, Tıkız C, Turan Y (2008) İstanbul Bel Ağrısı Fonksiyonel Skalasının Klinik Değişime Duyarlılığı. Lokomotor Dergisi 45:839–842 Duruoz T, Cerrahoglu L, Tıkız C, Turan Y (2008) İstanbul Bel Ağrısı Fonksiyonel Skalasının Klinik Değişime Duyarlılığı. Lokomotor Dergisi 45:839–842
12.
Zurück zum Zitat Hudson-Cook N, Tomes Nicholson K, Breen A (1989) A revised oswestry disability questionnaire. In: Roland MO, Jenner JR (eds) Back pain. Manchester University, Manchester, pp 187–204 Hudson-Cook N, Tomes Nicholson K, Breen A (1989) A revised oswestry disability questionnaire. In: Roland MO, Jenner JR (eds) Back pain. Manchester University, Manchester, pp 187–204
13.
Zurück zum Zitat Beck AT (1961) An Inventory for measuring depression. Arch Gen Psychiatry 1:561–571CrossRef Beck AT (1961) An Inventory for measuring depression. Arch Gen Psychiatry 1:561–571CrossRef
14.
Zurück zum Zitat Executive Summary of the Third Report of the National Chollesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001). JAMA 285:2486–2497 Executive Summary of the Third Report of the National Chollesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001). JAMA 285:2486–2497
15.
Zurück zum Zitat Bragt MC, Popeijus HE (2008) Peroxisome proliferator-activated receptors and the metabolic syndrome. Physiol Behav 94(2):187–197PubMedCrossRef Bragt MC, Popeijus HE (2008) Peroxisome proliferator-activated receptors and the metabolic syndrome. Physiol Behav 94(2):187–197PubMedCrossRef
16.
Zurück zum Zitat Jensterle M, Weber M, Pfeifer M, Prezelj J, Pfutzner A, Janez A (2008) Assessment of insulin resistance in young women with polycystic ovary syndrome. Int J Gynaecol Obstet 102(2):137–140PubMedCrossRef Jensterle M, Weber M, Pfeifer M, Prezelj J, Pfutzner A, Janez A (2008) Assessment of insulin resistance in young women with polycystic ovary syndrome. Int J Gynaecol Obstet 102(2):137–140PubMedCrossRef
17.
Zurück zum Zitat Santeusanio F (2008) Hypogonadism and the metabolic syndrome in men: an association to be considered. Nutr Metab Cardiovasc Dis 18(4):253–255PubMedCrossRef Santeusanio F (2008) Hypogonadism and the metabolic syndrome in men: an association to be considered. Nutr Metab Cardiovasc Dis 18(4):253–255PubMedCrossRef
18.
Zurück zum Zitat Ortonne JP (2008) Psoriasis, metabolic syndrome and its components. Ann Dermatol Venereol 135(Suppl 4):235–242CrossRef Ortonne JP (2008) Psoriasis, metabolic syndrome and its components. Ann Dermatol Venereol 135(Suppl 4):235–242CrossRef
19.
Zurück zum Zitat Fahri Bayram F, Gündogan K, Öztürk A, Yazıcı C (2006) Dünya’da ve Türkiye’de Metabolik Sendromun Dağılımı. Turkiye Klinikleri J Int Med Sci 2(3):18–24 Fahri Bayram F, Gündogan K, Öztürk A, Yazıcı C (2006) Dünya’da ve Türkiye’de Metabolik Sendromun Dağılımı. Turkiye Klinikleri J Int Med Sci 2(3):18–24
20.
Zurück zum Zitat Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM (2002) Intervertebral discs which cause low back pain secrete high levels of pro-inflammatory mediators. J Bone Joint Surg. 84:196–201CrossRef Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM (2002) Intervertebral discs which cause low back pain secrete high levels of pro-inflammatory mediators. J Bone Joint Surg. 84:196–201CrossRef
21.
Zurück zum Zitat Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM (2002) Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res 133:27–35PubMedCrossRef Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM (2002) Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res 133:27–35PubMedCrossRef
22.
Zurück zum Zitat Weiler C, Nerlich AG, Bachmeier BE, Boos N (2004) Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine 30:44–54 Weiler C, Nerlich AG, Bachmeier BE, Boos N (2004) Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine 30:44–54
23.
Zurück zum Zitat Genevay S, Stingelin S, Gabay C (2004) Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study. Ann Rheum Dis 63:1120–1123PubMedCrossRef Genevay S, Stingelin S, Gabay C (2004) Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study. Ann Rheum Dis 63:1120–1123PubMedCrossRef
24.
Zurück zum Zitat Karppinen J, Korhonen T, Malmivaara A, Paimela L, Kyllönen E, Lindgren KA et al (2003) Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine 28:750–753PubMed Karppinen J, Korhonen T, Malmivaara A, Paimela L, Kyllönen E, Lindgren KA et al (2003) Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine 28:750–753PubMed
25.
Zurück zum Zitat Mirtz TA, Greene L (2005) Is obesity a risk factor for low back pain? An example of using the evidence to answer a clinical question. Chiropr Osteopat 13(1):2PubMedCrossRef Mirtz TA, Greene L (2005) Is obesity a risk factor for low back pain? An example of using the evidence to answer a clinical question. Chiropr Osteopat 13(1):2PubMedCrossRef
26.
Zurück zum Zitat Han TS, Schouten JS, Lean ME, Seidell JC (1997) The prevalence of low back pain and associations with body fatness, fat distribution and height. Int J Obes Relat Metab Disord 21(7):600–607PubMedCrossRef Han TS, Schouten JS, Lean ME, Seidell JC (1997) The prevalence of low back pain and associations with body fatness, fat distribution and height. Int J Obes Relat Metab Disord 21(7):600–607PubMedCrossRef
27.
Zurück zum Zitat Stranjalis G, Tsamandouraki K, Sakas DE, Alamanos Y (2004) Low back pain in a representative sample of Greek population: analysis according to personal and socioeconomic characteristics. Spine 29(12):1355–1360PubMedCrossRef Stranjalis G, Tsamandouraki K, Sakas DE, Alamanos Y (2004) Low back pain in a representative sample of Greek population: analysis according to personal and socioeconomic characteristics. Spine 29(12):1355–1360PubMedCrossRef
28.
Zurück zum Zitat Kaila-Kangas L, Leino-Arjas P, Riihimaki H, Luukkonen R, Kirjonen J (2003) Smoking and overweight as predictors of hospitalization for back disorders. Spine 28(16):1860–1868PubMedCrossRef Kaila-Kangas L, Leino-Arjas P, Riihimaki H, Luukkonen R, Kirjonen J (2003) Smoking and overweight as predictors of hospitalization for back disorders. Spine 28(16):1860–1868PubMedCrossRef
29.
Zurück zum Zitat Wright D, Barrow S, Fisher AD, Horsley SD, Jayson MI (1995) Influence of physical, psychological and behavioral factors on consultations for back pain. Br J Rheumatol 34(2):156–161PubMedCrossRef Wright D, Barrow S, Fisher AD, Horsley SD, Jayson MI (1995) Influence of physical, psychological and behavioral factors on consultations for back pain. Br J Rheumatol 34(2):156–161PubMedCrossRef
30.
Zurück zum Zitat Janke EA, Collins A, Kozak AT (2007) Overview of the relationship between pain and obesity: what do we know? Where do we go next? J Rehabil Res Dev 44(2):245–262PubMedCrossRef Janke EA, Collins A, Kozak AT (2007) Overview of the relationship between pain and obesity: what do we know? Where do we go next? J Rehabil Res Dev 44(2):245–262PubMedCrossRef
31.
Zurück zum Zitat American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diab Care Suppl 1(27):5–10 American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diab Care Suppl 1(27):5–10
Metadaten
Titel
Evaluation of metabolic syndrome in patients with chronic low back pain
verfasst von
Mehmet Tuncay Duruöz
Yasemin Turan
Alev Gürgan
Hülya Deveci
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 3/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1693-x

Weitere Artikel der Ausgabe 3/2012

Rheumatology International 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.